keyword
MENU ▼
Read by QxMD icon Read
search

Psoriasis definition

keyword
https://www.readbyqxmd.com/read/30428753/special-aspects-of-biologics-treatment-in-psoriasis-management-in-pregnancy-lactation-surgery-renal-impairment-hepatitis-and-tuberculosis
#1
Kerasia-Maria Plachouri, Sophia Georgiou
Background of the article: Biologics are modern immunomodulatory drugs, whose use in the treatment of psoriasis has led to remarkable results in psoriatic patients. The administration of these agents in special population groups, such as patients with chronic infections and renal impairment, as well as perioperative, pregnant or lactating patients, has not been thoroughly addressed, mostly because these patients are excluded from clinical studies. MATERIALS AND METHODS: This report is an updated systematic overview of the use of biologics in the above mentioned types of patients and was conducted according to the PRISMA Guidelines for systematic reviews...
November 14, 2018: Journal of Dermatological Treatment
https://www.readbyqxmd.com/read/30426235/residual-symptoms-and-disease-burden-among-patients-with-psoriatic-arthritis-is-a-new-disease-activity-index-required
#2
Gamze Kilic, Erkan Kilic, Kemal Nas, Ayhan Kamanlı, İbrahim Tekeoglu
The aim of this study was to investigate residual symptoms or disease burden among patients with psoriatic arthritis (PsA) in remission or low disease activity (LDA) according to different outcome measures. A total of 126 patients with PsA were included and the following variables were assessed: Tender joint count (TJC), swollen joint count (SJC), patient's global assessment, physician's global assessment, pain, extra-articular manifestations, Psoriasis Area and Severity Index, Health Assessment Questionnaire, fatigue, Short Form-36, psoriatic quality of life, Hospital Anxiety and Depression Scale and C-reactive protein (CRP)...
November 13, 2018: Rheumatology International
https://www.readbyqxmd.com/read/30334253/definition-of-psoriasis-severity-in-routine-clinical-care-current-guidelines-fail-to-capture-the-complexity-of-long-term-psoriasis-management
#3
M Augustin, A Langenbruch, M Gutknecht, K Reich, A Körber, D Maaßen, U Mrowietz, D Thaçi, R von Kiedrowski, M A Radtke
BACKGROUND: Assessment of disease severity is an essential component of psoriasis management. Moderate-to-severe disease qualifies for systemic treatment but different definitions are used. OBJECTIVES: To analyse the impact of different severity definitions for psoriasis in real-world healthcare. METHODS: Cross-sectional data on 3274 patients with psoriasis from more than 200 dermatology offices and clinics across Germany were analysed for disease severity based on Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI)...
October 17, 2018: British Journal of Dermatology
https://www.readbyqxmd.com/read/30332374/biosimilar-agents-for-psoriasis-treatment-the-perspective-of-portuguese-patients
#4
Alexandra Azevedo, Andreia Bettencourt, Manuela Selores, Tiago Torres
INTRODUCTION: Biosimilars are highly similar copies of previously approved original biologic medicines. Their introduction on the market may yield cost reduction. The aim of this study was to evaluate the perspectives of psoriasis patients on biosimilar medications. MATERIALS AND METHODS: We conducted a 14 questions survey of psoriasis patients receiving biological therapy and followed-up in a dermatology department of a Portuguese tertiary care hospital. RESULTS: From a total of 108 patients included, 70...
September 28, 2018: Acta Médica Portuguesa
https://www.readbyqxmd.com/read/30323006/comparison-of-different-remission-and-low-disease-definitions-in-psoriatic-arthritis-and-evaluation-of-their-prognostic-value
#5
Laura C Coates, Alice B Gottlieb, Joseph F Merola, Caroline Boone, Annette Szumski, Amit Chhabra
OBJECTIVE: There is no agreement on the optimal definitions for assessing disease state in patients with psoriatic arthritis (PsA), and some of the commonly used definitions do not include assessment of skin lesions. We investigated the performance of various definitions in patients with PsA and psoriasis. METHODS: This was a posthoc analysis of data from the PRESTA study. The remission definitions analyzed were very low disease activity (VLDA) index, defined as 7/7 of the minimal disease activity (MDA) cutoffs; Disease Activity Index for PsA (DAPSA); and clinical (c-) DAPSA...
October 15, 2018: Journal of Rheumatology
https://www.readbyqxmd.com/read/30300876/effectiveness-end-points-in-real-world-studies-on-biological-therapies-in-psoriasis-systematic-review-with-focus-on-drug-survival
#6
Antonio Costanzo, Giovanna Malara, Claudio Pelucchi, Francesco Fatiga, Giovanna Barbera, Andrea Franchi, Carlotta Galeone
Psoriasis is a complex and chronic disease, and, in most cases, therapies are required during all patients' lifetime. The efficacy and safety profiles of biological therapies are well established, but their effectiveness is still open to discussion. We performed a systematic review to summarize how the effectiveness of biological therapies for psoriasis is measured in real-world studies and to understand whether drug survival, a recent alternative outcome to clinical ones, is a recurrent and valid outcome of effectiveness...
2018: Dermatology: International Journal for Clinical and Investigative Dermatology
https://www.readbyqxmd.com/read/30245900/implication-of-topical-steroids-in-the-onset-of-osteoporosis
#7
Asmaa Adel Milyani, Abdulmoein Eid Al-Agha
The systemic bioavailability of steroids has long been implicated as a cause for osteoporosis (OP); however, much less is known about the effect of topical steroids on bone homeostasis. This is a case of an 11-year-old male who is a known case of generalised pustular psoriasis for 8-year duration with frequent exacerbations controlled with topical betamethasone dipropionate. He presented with generalised progressive bone pain and positive history of bone fracture. The diagnosis of OP was established on the results of DEXA, which were -2...
2018: Case Reports in Pediatrics
https://www.readbyqxmd.com/read/30219765/what-should-be-the-primary-target-of-treat-to-target-in-psoriatic-arthritis
#8
Laura C Coates, Ennio Lubrano, Fabio Massimo Perrotta, Paul Emery, Philip G Conaghan, Philip S Helliwell
OBJECTIVE: Recommendations regarding "treat to target" in psoriatic arthritis (PsA) have stated that the target should be remission or inactive disease. Potential definitions include very low disease activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Activity Index for PsA (DAPSA) or clinical DAPSA (cDAPSA) remission. Our aim was to investigate the proportion of patients who fulfill these definitions and how much residual active disease remained. METHODS: This analysis used 2 datasets: first, trial data from the Tight Control of PsA (TICOPA) study, which included 206 patients with recent-onset (< 2 yrs) PsA receiving standard and biological disease-modifying antirheumatic drugs (DMARD); and second, an observational clinical dataset from Italy of patients receiving biological DMARD...
September 15, 2018: Journal of Rheumatology
https://www.readbyqxmd.com/read/30214149/focus-on-biosimilar-etanercept-bioequivalence-and-interchangeability
#9
REVIEW
Fabrizio Cantini, Maurizio Benucci
Background: The recent approval of reference etanercept (re-ETN) biosimilars SB4, GP2015, and HD203 produced relevant changes in the management of rheumatoid arthritis (RA), psoriatic arthritis, and ankylosing spondylitis due to the considerably lower cost of these products and the consequent savings. Aims: To review the pharmacodynamics, pharmacokinetics, efficacy, and safety of ETN biosimilars when employed as first-line therapy or after transition from re-ETN...
2018: Biologics: Targets & Therapy
https://www.readbyqxmd.com/read/30171803/trends-in-the-prevalence-and-incidence-of-psoriasis-and-psoriatic-arthritis-in-ontario-canada-a-population-based-study
#10
Lihi Eder, Jessica Widdifield, Cheryl F Rosen, Richard Cook, Ker-Ai Lee, Raed Alhusayen, J Michael Paterson, Stephanie Y Cheng, Shirin Jabbari, Willemina Campbell, Sasha Bernatsky, Dafna D Gladman, Karen Tu
OBJECTIVE: To estimate the prevalence and incidence of psoriasis and psoriatic arthritis (PsA) over time in Ontario, Canada. METHODS: We performed a population-based study of Ontario health administrative data using validated case definitions for psoriasis and PsA. We computed the crude and age/sex-standardized cumulative prevalence and incidence of psoriasis from 2000 to 2015. RESULTS: Among the 10,774,802 individuals aged 20 years and older residing in Ontario in 2015, we identified 273,238 and 18,655 patients with psoriasis and PsA, respectively, equating to cumulative prevalence estimates of 2...
September 1, 2018: Arthritis Care & Research
https://www.readbyqxmd.com/read/30135860/interaction-of-psoriasis-and-bullous-diseases
#11
REVIEW
Teruki Dainichi, Kenji Kabashima
Patients with psoriasis are frequently complicated with autoimmune bullous diseases, especially, pemphigoid diseases. It has been known that one-third cases of anti-laminin gamma1 pemphigoid, formerly anti-p200 pemphigoid, are associated with psoriasis whereas bullous pemphigoid is the most frequently associated bullous disease in psoriasis cases regardless of the lack of detectable levels of the accompanying anti-laminin gamma1 autoantibodies. Despite several suggestions, however, the definitive reason of the striking association of psoriasis and these autoimmune bullous diseases remains elusive...
2018: Frontiers in Medicine
https://www.readbyqxmd.com/read/30130618/incidence-and-risk-of-inflammatory-bowel-disease-in-patients-with-psoriasis-a-nationwide-20-year-cohort-study
#12
Alexander Egeberg, Jacob P Thyssen, Johan Burisch, Jean-Frederic Colombel
In psoriasis patients, incidence rates (IRs) of Crohn's disease (CD) and ulcerative colitis (UC) have been increased in epidemiological studies and certain clinical trials, yet the association remains poorly understood. We studied a 20-year nationwide cohort of 235,038 Danish adults with psoriasis and a 1:1 matched reference group. Less than 1% of psoriasis patients developed CD or UC during follow-up. IRs of CD were highest for younger women with psoriasis and patients with concurrent psoriatic arthritis (PsA), whereas men with psoriasis had particularly high IRs of UC compared with their non-psoriasis peers...
August 18, 2018: Journal of Investigative Dermatology
https://www.readbyqxmd.com/read/30075809/do-ethnicity-degree-of-family-relationship-and-the-spondyloarthritis-subtype-in-affected-relatives-influence-the-association-between-a-positive-family-history-for-spondyloarthritis-and-hla-b27-carriership-results-from-the-worldwide-asas-cohort
#13
Miranda van Lunteren, Alexandre Sepriano, Robert Landewé, Joachim Sieper, Martin Rudwaleit, Désirée van der Heijde, Floris van Gaalen
BACKGROUND: The Assessment of SpondyloArthritis international Society (ASAS) defines a positive family history (PFH) of spondyloarthritis (SpA) as the presence of ankylosing spondylitis (AS), acute anterior uveitis (AAU), reactive arthritis (ReA), inflammatory bowel disease (IBD), and/or psoriasis in first-degree relatives (FDR) or second-degree relatives (SDR). In two European cohorts, a PFH of AS and AAU, but not other subtypes, was associated with human leukocyte antigen B27 (HLA-B27) carriership in patients suspected of axial SpA (axSpA)...
August 3, 2018: Arthritis Research & Therapy
https://www.readbyqxmd.com/read/30035729/the-role-of-the-stress-in-the-development-of-severe-forms-of-psoriasis-case-report
#14
A Daschuk, Ye Dobrzhanskaya, N Pustovaya
The purpose of the study was to follow the casual mechanism of exacerbation, progression and formation of severe forms of psoriasis, as well as the progression of cutaneous manifestation of psoriasis with the definition of the role of stress response in their development by analyzing features of the psoriasis dynamics on the example of reviewing clinical case in anamnesis. MATERIALS AND METHODS: Examination of the psychosomatic condition and stress-making immunoneuroendocrine system of the patient with psoriasis was conducted at the beginning of disease and in the remission period of psoriasis...
June 2018: Georgian Medical News
https://www.readbyqxmd.com/read/30033578/ex-vivo-fluorescence-confocal-microscopy-for-intraoperative-real-time-diagnoses-of-cutaneous-inflammatory-diseases-a-preliminary-study
#15
Laura Bertoni, Paola Azzoni, Camilla Reggiani, Alessandra Pisciotta, Gianluca Carnevale, Johanna Chester, Shaniko Kaleci, Luca Reggiani Bonetti, Anna Maria Cesinaro, Caterina Longo, Giovanni Pellacani
Ex vivo fluorescence confocal microscopy (FCM) is an innovative imaging tool that can be used intraoperatively to obtain real-time images of untreated excised tissue with almost histologic resolution. As inflammatory diseases often share overlapping clinical features, histopathology evaluation is required for dubious cases, delaying definitive diagnoses, and therefore therapy. This study identifies key-features at ex vivo FCM for differential diagnoses of cutaneous inflammatory diseases, in particular, psoriasis, eczema, lichen planus and discoid lupus erythematosus...
July 22, 2018: Experimental Dermatology
https://www.readbyqxmd.com/read/29904911/metabolic-syndrome-and-risk-of-incident-psoriasis-prospective-data-from-the-hunt-study-norway
#16
I Snekvik, T I L Nilsen, P R Romundstad, M Saunes
BACKGROUND: Metabolic syndrome has been associated with psoriasis in cross-sectional studies, but data from prospective studies are sparse. OBJECTIVES: To prospectively examine whether metabolic syndrome and its components are associated with risk of incident psoriasis in a large population-based study using objective measurements of cardiovascular disease risk factors. METHODS: We used data from two consecutive surveys of the HUNT Study, Norway (HUNT2, 1995-1997, and HUNT3, 2006-08)...
June 14, 2018: British Journal of Dermatology
https://www.readbyqxmd.com/read/29874363/core-outcome-sets-for-psoriasis-clinical-trials-definition-consensus-and-acceptance
#17
Bruce E Strober, Kenneth B Gordon
No abstract text is available yet for this article.
October 1, 2018: JAMA Dermatology
https://www.readbyqxmd.com/read/29852521/generalized-pustular-psoriasis-a-model-disease-for-specific-targeted-immunotherapy-systematic-review
#18
REVIEW
Alexander Boehner, Alexander A Navarini, Kilian Eyerich
Generalized pustular psoriasis (GPP) is a rare, multisystemic skin disease characterized by recurrent episodes of pustulation. GPP can be life-threatening and is often difficult to treat. In the era of precision medicine in dermatology, GPP stands exemplary for both challenges and chances-while new treatments offer great hope, there is urgent need for better definition and stratification of this severe and heterogeneous disease. Our objective was to systematically review the literature for evidence of efficacy of targeted immunotherapy and their mode of action in the context of clinical phenotype, classification and pathogenesis of adult GPP...
October 2018: Experimental Dermatology
https://www.readbyqxmd.com/read/29848153/efficacy-and-survival-of-biologic-agents-in-psoriasis-a-practical-real-life-12-year-experience-in-a-french-dermatology-department
#19
Hélène Roche, Kevin Bouiller, Eve Puzenat, Elise Deveza, Blandine Roche, Fabien Pelletier, Alison van de Laak, Anne Sophie Dupond, Charlée Nardin, François Aubin
BACKGROUND: Drug survival in a real-life setting is critical to long-term use of biologics for psoriasis. OBJECTIVE: We describe our 12-year experience with biologics in psoriasis patients. PATIENTS AND METHODS: All patients treated with biologics including infliximab, adalimumab, etanercept and ustekinumab for psoriasis vulgaris between January 2005 and December 2016 were retrospectively analyzed. RESULTS: In total, 545 treatment series were administered to 269 patients, including 211 treatment series with adalimumab, 135 with etanercept, 77 with infliximab and 122 with ustekinumab...
May 31, 2018: Journal of Dermatological Treatment
https://www.readbyqxmd.com/read/29792371/biologics-monitoring-incongruity-between-recommendations-and-clinician-monitoring-trends
#20
Anish Nadkarni, Kimberly Hyde, Leah A Cardwell, Steven R Feldman
BACKGROUND: Biologics are a commonly used treatment for moderate to severe psoriasis. Monitoring laboratory test overuse provide little definitive benefit to patients. OBJECTIVE: We aim to query a Humana database to gain insight regarding current dermatologist laboratory monitoring practices for psoriasis patients on biologics. METHODS: Data were obtained from the Humana database. Our cohort included 333 patients with primary ICD-9 diagnosis of psoriasis (696...
May 24, 2018: Journal of Dermatological Treatment
keyword
keyword
110315
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"